BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
89 hedge funds and large institutions have $255M invested in BioSpecifics Technologies Corp. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 8 closing their positions.
14% more capital invested
Capital invested by funds: $223M → $255M (+$31.4M)
3% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 36
7% less funds holding
Funds holding: 96 → 89 (-7)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$20M |
| 2 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$2.02M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$1.73M |
| 4 |
Renaissance Technologies
New York
|
+$1.05M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$3.94M |
| 2 |
SEI Investments
Oaks,
Pennsylvania
|
-$2.2M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$917K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$908K |
| 5 |
Two Sigma Investments
New York
|
-$655K |
BSTC Hedge Fund Activity: Q1 2017 in Review
89 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2017, worth a combined $255M — up 14% from $223M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BSTC and 6 opened new positions — a net loss of 2 holders — while 36 trimmed existing stakes and 35 added.
The largest buyer was BlackRock, adding an estimated $20M. The largest seller was RK Capital Management (Colorado), exiting entirely with an estimated $3.94M sold.
- 89 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2017, down from 96 in Q4 2016.
- Funds reported $255M of BioSpecifics Technologies Corp. stock for Q1 2017, up 14% quarter-over-quarter.
- 6 funds opened new BioSpecifics Technologies Corp. positions in Q1 2017 and 8 closed out, a net change of -2 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q1 2017 was BlackRock, an estimated $20M added.
- The largest BioSpecifics Technologies Corp. seller in Q1 2017 was RK Capital Management (Colorado), an estimated $3.94M sold.
Based on aggregated 13F filings for Q1 2017.